Hypha Labs, Inc.
FUNI
$0.01
$0.00-7.86%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.91M | 2.11M | 2.94M | 2.96M | 3.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.91M | 2.11M | 2.94M | 2.96M | 3.04M |
| Operating Income | -1.91M | -2.11M | -2.94M | -2.96M | -3.04M |
| Income Before Tax | -2.16M | -2.28M | -3.10M | -3.02M | -3.19M |
| Income Tax Expenses | -- | -- | -- | -11.80K | -34.50K |
| Earnings from Continuing Operations | -2.16 | -2.28 | -3.10 | -3.01 | -3.15 |
| Earnings from Discontinued Operations | -- | -- | -- | 0.00 | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.16M | -2.28M | -3.10M | -3.01M | -3.15M |
| EBIT | -1.91M | -2.11M | -2.94M | -2.96M | -3.04M |
| EBITDA | -1.90M | -2.10M | -2.93M | -2.95M | -3.04M |
| EPS Basic | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 596.25M | 567.88M | 540.78M | 511.23M | 482.01M |
| Average Diluted Shares Outstanding | 596.25M | 567.88M | 540.78M | 511.23M | 482.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |